D-0247-2026 Class III Ongoing

Recalled by Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

FDA drug recall D-0247-2026 was initiated by Zydus Pharmaceuticals (USA) Inc on Dec 19, 2025 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface. The recall status is ongoing. Affected quantity: 2,136 1000-count bottles.

Recall details

Product Type
Drugs
Report Date
Jan 7, 2026
Initiation Date
Dec 19, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,136 1000-count bottles

Product description

traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10

Reason for recall

Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

Distribution pattern

Nationwide in the USA

Code information

Lot # EA00237A, Exp Date: 04/30/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0247-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0247-2026. Report a data issue: hello@regdatalab.com.